DK3199161T3 - Farmaceutisk præparat - Google Patents

Farmaceutisk præparat Download PDF

Info

Publication number: DK3199161T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical preparation; pharmaceutical; preparation
Prior art date: 2014-09-25

Application number

DK15844737.5T

Other languages

English (en)

Inventor

Hiroshi Oda

Yuuki Suzuki

Original Assignee

Kowa Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-09-25

Filing date

2015-09-25

Publication date

2022-01-03

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55581240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3199161(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-09-25 Application filed by Kowa Co filed Critical Kowa Co

2022-01-03 Application granted granted Critical

2022-01-03 Publication of DK3199161T3 publication Critical patent/DK3199161T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1468—Containers characterised by specific material properties
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
- B65D81/30—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants by excluding light or other outside radiation
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/16—Nitrogen-containing compounds
- C08K5/34—Heterocyclic compounds having nitrogen in the ring
- C08K5/3467—Heterocyclic compounds having nitrogen in the ring having more than two nitrogen atoms in the ring
- C08K5/3472—Five-membered rings
- C08K5/3475—Five-membered rings condensed with carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
- C08K2003/2237—Oxides; Hydroxides of metals of titanium
- C08K2003/2241—Titanium dioxide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Ophthalmology & Optometry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Mechanical Engineering (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Packages (AREA)
Wrappers (AREA)

DK15844737.5T 2014-09-25 2015-09-25 Farmaceutisk præparat DK3199161T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2014195279		2014-09-25
PCT/JP2015/077015 WO2016047721A1 (ja)	2014-09-25	2015-09-25	医薬製剤

Publications (1)

Publication Number	Publication Date
DK3199161T3 true DK3199161T3 (da)	2022-01-03

Family

ID=55581240

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK15844737.5T DK3199161T3 (da)	2014-09-25	2015-09-25	Farmaceutisk præparat

Country Status (17)

Country	Link
US (2)	US20170304199A1 (da)
EP (1)	EP3199161B1 (da)
JP (6)	JP6244038B2 (da)
KR (1)	KR101846804B1 (da)
CN (1)	CN106794186B (da)
BR (1)	BR112017006149A2 (da)
CA (1)	CA2962628C (da)
DK (1)	DK3199161T3 (da)
ES (1)	ES2901997T3 (da)
HU (1)	HUE057834T2 (da)
MX (1)	MX387483B (da)
MY (1)	MY178371A (da)
PL (1)	PL3199161T3 (da)
PT (1)	PT3199161T (da)
SG (1)	SG11201702298VA (da)
TW (1)	TWI671071B (da)
WO (1)	WO2016047721A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20170266080A1 (en) *	2014-09-25	2017-09-21	Kowa Company, Ltd.	Pharmaceutical product
JP2019142773A (ja) *	2016-06-15	2019-08-29	興和株式会社	眼科用組成物
WO2017217477A1 (ja) *	2016-06-15	2017-12-21	興和株式会社	水性組成物
EP3590514A4 (en) *	2017-02-28	2021-01-06	Kowa Company, Ltd.	PHARMACEUTICAL PREPARATION
JP7108596B2 (ja)	2017-02-28	2022-07-28	興和株式会社	医薬
KR20230124753A (ko) *	2017-02-28	2023-08-25	코와 가부시키가이샤	의약품
KR20190128657A (ko) *	2017-03-27	2019-11-18	코와 가부시키가이샤	의약 제제
WO2021195256A1 (en) *	2020-03-24	2021-09-30	Aerie Pharmaceuticals, Inc.	Pharmaceutical preparation
JPWO2023195543A1 (da) *	2022-04-08	2023-10-12
JP7663792B1 (ja)	2024-07-22	2025-04-16	興和株式会社	医薬
JP7595233B1 (ja)	2024-07-22	2024-12-05	興和株式会社	医薬
JP7635471B1 (ja) *	2024-09-12	2025-02-25	興和株式会社	医薬製剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3879940B2 (ja) *	1995-07-11	2007-02-14	旭化成ファーマ株式会社	塩酸ファスジル注射剤
MY139797A (en) *	2004-11-29	2009-10-30	Kowa Co	(s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1, 4-homopiperazine hydrochloride dihydrate
JP4972552B2 (ja) *	2005-07-12	2012-07-11	興和株式会社	緑内障を予防又は治療する薬剤
US20080064681A1 (en) *	2006-09-11	2008-03-13	Hiroyoshi Hidaka	Therapeutic agent for treating glaucoma
CA2731271A1 (en) *	2008-07-25	2010-01-28	Asahi Kasei Pharma Corporation	Stable aqueous solution composition containing sulfonamide compound
EP2990040B1 (en) *	2013-04-24	2019-12-04	Kyushu University, National University Corporation	Therapeutic agent for eyeground disease
US10034885B2 (en) *	2014-09-24	2018-07-31	Kowa Company, Ltd.	Corneal thickness modulating agent
PT3199160T (pt) *	2014-09-25	2020-04-08	Kowa Co	Composição aquosa
US20170266080A1 (en) *	2014-09-25	2017-09-21	Kowa Company, Ltd.	Pharmaceutical product
US10220043B2 (en) *	2014-12-12	2019-03-05	Kowa Company, Ltd.	Aqueous composition
KR20160108121A (ko) *	2015-03-06	2016-09-19	코와 가부시키가이샤	수성 조성물
US9844556B2 (en) *	2015-03-25	2017-12-19	Megumi Honjo	Preventive/therapeutic method and preventive/therapeutic agent for complications after cataract surgery
JP6928479B2 (ja) *	2017-05-12	2021-09-01	学校法人順天堂	拒絶反応抑制剤

2015
- 2015-09-25 KR KR1020177007055A patent/KR101846804B1/ko active Active
- 2015-09-25 MY MYPI2017700949A patent/MY178371A/en unknown
- 2015-09-25 HU HUE15844737A patent/HUE057834T2/hu unknown
- 2015-09-25 EP EP15844737.5A patent/EP3199161B1/en active Active
- 2015-09-25 CN CN201580051710.XA patent/CN106794186B/zh active Active
- 2015-09-25 MX MX2017003945A patent/MX387483B/es unknown
- 2015-09-25 DK DK15844737.5T patent/DK3199161T3/da active
- 2015-09-25 JP JP2016550378A patent/JP6244038B2/ja active Active
- 2015-09-25 SG SG11201702298VA patent/SG11201702298VA/en unknown
- 2015-09-25 ES ES15844737T patent/ES2901997T3/es active Active
- 2015-09-25 TW TW104131864A patent/TWI671071B/zh active
- 2015-09-25 US US15/514,155 patent/US20170304199A1/en not_active Abandoned
- 2015-09-25 PT PT158447375T patent/PT3199161T/pt unknown
- 2015-09-25 PL PL15844737T patent/PL3199161T3/pl unknown
- 2015-09-25 WO PCT/JP2015/077015 patent/WO2016047721A1/ja active Application Filing
- 2015-09-25 CA CA2962628A patent/CA2962628C/en active Active
- 2015-09-25 BR BR112017006149A patent/BR112017006149A2/pt not_active Application Discontinuation
2017
- 2017-11-09 JP JP2017216093A patent/JP2018027979A/ja not_active Ceased
2019
- 2019-08-21 JP JP2019150781A patent/JP2020002151A/ja active Pending
2021
- 2021-05-06 JP JP2021078646A patent/JP2021176842A/ja active Pending
2023
- 2023-01-31 JP JP2023012898A patent/JP2023052792A/ja active Pending
2024
- 2024-03-18 US US18/608,109 patent/US20240216272A1/en active Pending
- 2024-09-30 JP JP2024169861A patent/JP2024174093A/ja active Pending

Also Published As

Publication number	Publication date
WO2016047721A1 (ja)	2016-03-31
JP2021176842A (ja)	2021-11-11
US20240216272A1 (en)	2024-07-04
JPWO2016047721A1 (ja)	2017-06-22
SG11201702298VA (en)	2017-04-27
JP2020002151A (ja)	2020-01-09
JP2024174093A (ja)	2024-12-13
KR101846804B1 (ko)	2018-04-06
TWI671071B (zh)	2019-09-11
PL3199161T3 (pl)	2022-04-11
JP2018027979A (ja)	2018-02-22
EP3199161B1 (en)	2021-12-15
US20170304199A1 (en)	2017-10-26
CN106794186A (zh)	2017-05-31
EP3199161A1 (en)	2017-08-02
PT3199161T (pt)	2022-02-08
TW201613603A (en)	2016-04-16
CA2962628A1 (en)	2016-03-31
CN106794186B (zh)	2020-06-05
MX387483B (es)	2025-03-18
JP6244038B2 (ja)	2017-12-06
ES2901997T3 (es)	2022-03-24
BR112017006149A2 (pt)	2017-12-26
JP2023052792A (ja)	2023-04-12
HUE057834T2 (hu)	2022-06-28
MX2017003945A (es)	2017-06-30
KR20170058367A (ko)	2017-05-26
CA2962628C (en)	2023-01-10
MY178371A (en)	2020-10-09
EP3199161A4 (en)	2018-04-11

Publication	Publication Date	Title
DK3089741T3 (da)	2021-06-07	Farmaceutiske sammensætninger omfattende azd9291
BR112016023628A2 (pt)	2018-05-15	composições farmacêuticas.
HRP20181479T1 (hr)	2018-11-02	Tekući farmaceutski sastav
PL4070788T3 (pl)	2023-07-10	Formulacje farmaceutyczne
HUE043290T2 (hu)	2019-08-28	Adagoló kapszula
DK3199161T3 (da)	2022-01-03	Farmaceutisk præparat
HUE050779T2 (hu)	2021-01-28	Folyékony gyógyszerészeti készítmény
DK3463345T3 (da)	2023-01-09	Farmaceutiske kombinationer
EP3246047C0 (en)	2024-12-25	COMBINATION MEDICATION
DK3191085T3 (da)	2021-06-28	Misbrugsresistente farmaceutiske sammensætninger
UA31197S (uk)	2016-01-12	Таблетка
HUE057717T2 (hu)	2022-06-28	Metotrexát készítmény
DK3166473T3 (da)	2020-04-27	Oftalmoskoper
DK3280447T3 (da)	2019-05-13	Farmaceutiske formuleringer
HUE048790T2 (hu)	2020-09-28	Vizes készítmény
DK3148513T3 (da)	2020-05-25	Ceritinib-formulering
EP3395344A4 (en)	2019-09-04	MEDICINE
HUE047581T2 (hu)	2020-05-28	Készítmény
HUE050881T2 (hu)	2021-01-28	Gyógyszerkészítmény
EP3217965C0 (en)	2024-04-24	Pharmaceutical processing
DK3193856T3 (da)	2021-09-06	Formulering
EP3181125C0 (en)	2025-02-19	CAPSULE FORMULATION
DK3288967T3 (da)	2020-02-10	Farmaceutisk forbindelse
LT3188755T (lt)	2020-12-28	Vakcina
HUE054775T2 (hu)	2021-09-28	Benzidamint tartalmazó gyógyászati készítmény